SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-21-009738
Filing Date
2021-02-01
Accepted
2021-02-01 08:34:21
Documents
2
Group Members
NOVARTIS AGNOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tm214797d1_sc13ga.htm SC 13G/A 79466
2 EXHIBIT 4 tm214797d1_ex-4.htm EX-4 8868
  Complete submission text file 0001104659-21-009738.txt   90076
Mailing Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000
Business Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000 41-61-324-6210
Novartis Bioventures Ltd (Filed by) CIK: 0001297709 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Subject) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90283 | Film No.: 21574795
SIC: 2834 Pharmaceutical Preparations